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ABSTRACT
Coronary perforation is a rare complication of percutaneous 
coronary intervention and is potentially catastrophic. Coronary 
perforation may lead to pericardial effusion with or without 
cardiac tamponade and if not diagnosed early on and treated 
properly it is life-threatening. We present a case of percutane-
ous coronary intervention complicated by coronary perforation, 
which was quickly treated by the reversal of anticoagulation, 
prolonged balloon inflation and a coated-stent, using the 
double guiding catheter technique.
 
 
DESCRIPTORS: Percutaneous coronary intervention. Stents. 
Cardiac catheters.
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RESUMO
Tratamento com a Técnica de Duplo  
Cateter-Guia de Perfuração Coronária Tipo III
A perfuração coronária é uma complicação rara da interven-
ção coronária percutânea e potencialmente catastrófica. Pode 
levar ao derrame pericárdico, com ou sem tamponamento 
cardíaco, e, se não diagnosticada com precocidade e tratada 
adequadamente, pode levar ao óbito. Relatamos o caso 
de uma intervenção coronária percutânea complicada com 
perfuração coronária, rapidamente tratada com reversão da 
anticoagulação, insuflação prolongada com balão e implante 
de stent recoberto pela técnica do duplo cateter-guia.
DESCRITORES: Intervenção coronária percutânea. Stents. 
Cateteres cardíacos.
C oronary perforation (CP) is a rare complication in percutaneous coronary intervention (PCI), which can lead to pericardial effusion and cardiac tam-
ponade. If undiagnosed and not treated promptly, it can 
lead to death. The incidence the CPs associated with 
PCI is approximately 0.1 to 0.6%, and its occurrence 
is associated with complex lesions, especially those 
with severe calcification and chronic occlusion, use of 
rotational atherectomy devices, and use of hydrophilic 
guidewires.
In 1994, Ellis et al.1 classified coronary perforations 
on a scale of 1 to 4, based on the angiographic criteria 
(Table 1). A subsequent study evaluated the in-hospital 
outcome of patients with CP and concluded that those with 
large perforations (type III) had a mortality rate of 21.4% 
vs. ≤ 1%, when compared to type I or II perforations.2
The purpose of this case report was to describe the 
particular management of a CP case that occurred in 
a patient submitted to elective PCI in an interventional 
cardiology service with a large number of procedures, 
unexpectedly, after pre-dilation with balloon (balloon: 
artery ratio < 1).
CASE REPORT
Male patient, 66 years old, with a history of 
systemic arterial hypertension and dyslipidemia, had 
grade II stable angina, having been referred for elec-
tive angioplasty after coronary angiography assessment.
The coronary angiography showed no lesions in 
the right coronary and left circumflex arteries; the left 
anterior descending (LAD) artery had a mild proximal 
Case Report
Martins-Filho et al. 
Coronary Perforation Treated with Double-Catheter Guide
Rev Bras Cardiol Invasiva. 
2013;21(4):401-5
402
lesion (30%) and a 90% eccentric segmental lesion in 
its middle third (Figure 1A). A quantitative coronary 
angiography (QCA) was performed offline (CAAS II; Pie 
Medical Imaging, Maastricht, the Netherlands), which 
showed that the reference diameter of the target vessel 
was 3.06 mm (Figure 1B).
Laboratory tests at the clinical assessment pre-PCI 
were within normal limits. The patient received 300 mg 
of clopidogrel the day before the procedure and was 
already taking 100 mg/day of acetylsalicylic acid (ASA). 
The PCI planning included pre-dilation, followed 
by implantation of a bioresorbable vascular scaffold 
(BVS, Abbott Vascular, Temecula, California, United 
States), according to a specific clinical trial protocol. 
The procedure was performed through the right femoral 
approach with 6F sheath, and 100 IU/kg of unfraction-
ated heparin were administered during the procedure, 
aiming for activated clotting time (ACT) > 250/s.
After selective catheterization of the left coronary 
ostium with JL 3.5 6F guide catheter (Figure 2A), the 
lesion was crossed without difficulty with a 0.014-inch 
BMW® guidewire (Abbott Vascular, Temecula, California, 
United States). Then, pre-dilation was performed using a 
3.25 × 20 mm noncompliant NC Trek® balloon catheter 
(Abbott Vascular, Temecula, California, United States) up 
to 10 atm, aiming at a balloon: artery ratio close to 1 
(ratio of 0.97, measured offline at QCA), according to 
technical recommendations for BVS implant (Figure 2B). 
The control angiography after pre-dilation showed 
clear contrast extravasation into the pericardium, through 
an orifice ≥ 1 mm, indicating type III CP associated 
with distal vessel occlusion (Figure 2C). Immediately, the 
orifice area was sealed by means of prolonged inflation 
at low pressure (4 atm) using the same balloon catheter 
used in pre-dilation, for about 20 minutes. Simultane-
ously, anticoagulation reversal was performed with 50 
mg of intravenous protamine in order to achieve ACT 
< 150 seconds.
The echocardiography showed mild pericardial 
effusion, without hemodynamic repercussions. The 
BVS implantation was then contraindicated due to the 
complication.
It was decided to employ the double guide-catheter 
technique4-7 in order to implant a long drug-eluting 
stent, covering the entire lesion segment, followed by 
implantation of a short in-stent polytetrafluoroethylene-
coated (PTFE) stent only in the CP site. For that, a 
second arterial access was attained through a left 
femoral artery puncture, followed by the placement of 
another 6F sheath. Then, a JL 3.5 6F guiding catheter 
was positioned in parallel to the first, in the left coro-
nary ostium. A 0.014-inch guidewire (ChoICE® Floppy, 
Boston Scientific, Natick, United States) was advanced 
until the proximal border of the balloon catheter that 
was inflated. Quickly and synchronously, the balloon 
TABLE 1  
Modified Ellis classification1,3  
for coronary perforations
Type I Extraluminal crater without linear 
extravasation of contrast suggesting 
dissection
Type II Pericardial or myocardial blush, with exit 
orifice < 1 mm
Type III Clear contrast extravasation into the 
pericardium through orifice ≥ 1 mm in 
diameter
Type IV Perforation with spillage of contrast 
directly into the left ventricle, coronary 
sinus or other vascular chamber, excluding 
the pericardium
Figure 1 – (A) Reference angiography before the procedure. (B) Quantitative coronary angiography before and during pre-dilation showing the bal-
loon: artery ratio of 0.97. 
A B
Vessel reference
diameter: 3.06 mm Balloon diameter: 2.98 mm
Balloon: artery ratio 0.97
l r f r
i t r: .  
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was deflated; the second guidewire was introduced 
to a distal point in the LAD artery, and the balloon 
catheter was once more inflated (Figure 2D). A 3 × 
24 mm Endeavor® drug-eluting stent (Medtronic Inc., 
Minneapolis, United States) was advanced through the 
second guidewire to the proximal border of the balloon 
catheter inflated at up to 10 atm in the perforation area. 
In a quick maneuver, the balloon was deflated and 
retracted, and the stent was advanced and implanted at 
the perforation site, covering the entire segment of the 
lesion in the middle third of the LAD (Figures 2E and 
2F). Then, a 3.5 × 12 mm coated Jostent GraftMaster® 
stent (Abbott Vascular – Temecula, California, United 
States) was implanted (released with 14 atm) in-stent 
at the perforation site, using the same technique of 
rapid deflation of the balloon and stent implantation 
(Figure 2G and 2G1).
The control angiography showed complete CP 
sealing and no residual lesion (Figure 2H).
Echocardiograms during the procedure and three 
hours later showed minimal pericardial effusion; there 
was no significant increase in troponin. The echo-
cardiography was repeated on the following day and 
showed no additional changes. The patient was referred 
to the coronary care unit, and was discharged on the 
day after the procedure and prescribed dual antiplatelet 
therapy for 12 months.
DISCUSSION
During PCI, CP can occur as a consequence of 
advancement of the guidewire, balloon, or stent; stent 
release; oversizing of stents/balloons; and stent fracture 
or subintimal passage of balloon/stent, leading to severe 
dissections and perforation. It has been reported that 
perforation after stent implantation is mainly caused by 
excessive dilation or implantation of a stent oversized 
for the treated vessel.
The main cause of CP is the improper handling 
of the guidewire, either when crossing the lesion, by 
positioning it inadvertently out of the arterial bed, or at 
the distal arterial bed, beyond the ideal point, pushing 
and perforating. Guidewires with hydrophilic coating, 
particularly those with a polymer-coated tip, which are 
indicated in severe coronary lesions, occlusions, and 
severe tortuosity, cause increased risk of perforation 
due to their low coefficient of friction and easy distal 
migration.8-13 Although more frequent, trauma-related 
CP by guidewire is generally easily well-controlled, 
and the occurrence of significant pericardial effusion 
with cardiac tamponade is rare.14
The oversizing of stents/balloons brings increased 
risk of CP during PCI. Ajluni et al.15 reported that per-
forations were more frequent when the balloon: artery 
ratio was 1.3 ± 0.3, when compared to PCIs in which 
Figure 2 – (A) Coronary angiography in left anterior oblique view showing subocclusive lesion in the mid-third of left anterior descending artery. (B) 
Pre-dilation with noncompliant balloon catheter Trek NC (Abbott Vascular, Inc.). (C) Injection of control after pre-dilation showing type III coronary 
perforation with contrast extravasation and distal TIMI flow grade 0. (D) Prolonged inflation (20 minutes) of the balloon catheter at the perforation site. 
(E) Second guide catheter, through which the drug-eluting and coated stents will be advanced. (F) Release of drug-eluting stent, covering the entire 
segment of the lesion in the mid-third of the left anterior descending artery. (G and G1) Positioning and release of coated stent at the perforation site 
with fast balloon catheter deflation maneuver, which remained inflated. (H) Final control injection (white arrows indicate the two guide catheters). 
A
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the balloon: artery ratio was 1.0 ± 0.3 (P  <  0.001). 
Similarly, Ellis et al. 1 published a registry of patients 
undergoing PCI in which those who suffered CP had 
a balloon: artery ratio of 1.19 ± 0.17 vs. 0.92 ± 0.16 
in those without this complication (P = 0.03). This ob-
servation was confirmed in another large randomized 
study in which a balloon: artery ratio > 1.1 increased 
the risk of severe dissection and perforation by two to 
three fold, when compared to a balloon: artery ratio < 
1.1.3 In the present case, the balloon: artery ratio was 
0.97 and therefore, it did not justify the complication 
that occurred (Figure 1).
Silva et al.16 reported their experience in the occur-
rence of coronary perforations at Instituto Dante Pazzanese 
de Cardiologia in São Paulo (Brazil) from December 
2007 to January 2012, in which 5,585 patients were 
submitted to PCI and 18 had CP (0.32%). In that group, 
the LAD was the most often treated vessel (61.1%), as 
well as Type C lesions (61.1%). Chronic occlusions were 
treated in 27.8% of cases. Most coronary perforations 
had lower complexity according to the modified Ellis 
classification. The device with the balloon catheter was 
responsible for the CP in 61.1% of cases. Prolonged 
inflation with a balloon catheter and heparin reversal 
with protamine was performed in 72.2% and 88.9% 
of cases, respectively. There were no deaths associated 
with CP. Female gender and chronic occlusions were 
predictors of CP, according to the multivariate analysis.
In the present case, in order to minimize the time 
between the inflated balloon withdrawal at the CP site 
and introduction and coated stent implantation, it was 
decided to use the double guide-catheter technique 
(Figure 3). This technique was first described by Silver 
et al.6 for the treatment of type III CP, sealed with a 
stent coated with PTFE, which was released through a 
second guide catheter inserted into the contralateral 
femoral artery, while the perforation site was controlled 
and sealed with the angioplasty balloon. Ben-Gal et 
al.5 have recently described the first series of patients 
treated by double catheter technique. The number of 
patients included in this study was not great enough 
to generate definitive conclusions, but the observation 
of a relatively lower rate of adverse events using the 
double guide-catheter technique appears to favor this 
approach.
The technique allows for the preparation and si-
multaneous parallel insertion of another system includ-
ing catheter-guide, guidewire, and coated stent, while 
the temporary sealing of the perforation is performed 
through the system used for the PCI that resulted in 
the CP. Due to the high profile, there are limitations 
in the maneuvering of stents coated with PTFE, and 
it is sometimes difficult to reach the perforation site. 
Furthermore, the inner lumen of the guide catheters 
commonly used in PCI (6F, 7F) is not sufficient for the 
passage of a balloon and a stent coated with PTFE in 
parallel.
This technique of double-guiding catheter requires 
some considerations. First, in case of impending car-
diac tamponade, in which a coated stent coated can 
Figure 3 – Schematic diagram showing the double guide-catheter technique. (A) Balloon used in the angioplasty inflated at low pressure (4 atm) at 
the perforation site. (B) Careful withdrawal of the first guide-catheter and catheterization of the coronary ostium with the second guide-catheter. (C 
and D). Advancement of the second guide-catheter, crossing the perforation site with quick balloon deflation, allowing its passage. (E) Coated stent 
advancing over the second guide catheter. (F). Rapid deflation maneuver, balloon withdrawal and coated stent implantation at the perforation site.
A
D
B
E
C
F
B
Inflated balloon at
the perforation site Second guide catheter
Second guidewire
Second guidewire crossing
the perforation site
Balloon is rapidly
deflated Second guidewire
is rapidly advanced Coated stent over the second guidewire
Balloon is rapidly deflated and coated stent
is released at the perforation site
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be easily and quickly implanted at the perforation site, 
the surgeon may consider pericardiocentesis, and then 
remove the balloon and implant the coated stent, keeping 
the continuous drainage of the pericardium. For such 
patients, the double guide-catheter technique might not 
be required. Secondly, the surgeon must be aware of 
when to stop the procedure and indicate emergency 
surgical intervention. The hemodynamic stability can 
hardly be maintained in patients with large perforations 
involving extensive areas of viable myocardium. In such 
cases, if a stent coated with PTFE cannot be easily 
implanted, circulatory support and surgical intervention 
should be considered immediately.
Successful treatment of this serious complication is 
associated with the rapid control of pericardial effusion, 
as mortality is closely linked to the development of 
cardiac tamponade. Treatment requires early detection 
and angiographic perforation classification; immediate 
balloon inflation at the perforation site; heparin neu-
tralization; platelet transfusion in cases associated with 
the use of IIb/IIIa glycoprotein inhibitors, and coated 
stent implantation, when necessary. For that purpose, 
upon suspicion of CP during balloon/stent inflation 
with a balloon: artery ratio > 1.3, the balloon should 
be deflated, and without removing it from the site, 
an angiography should be rapidly performed for CP 
confirmation; if confirmed, the balloon should be im-
mediately reinflated with low pressure, while checking 
the vessel occlusion/CP with a small contrast injection.
The double guide-catheter technique may be 
considered in some situations, especially when the 
first guide catheter is being used for persistent balloon 
inflation in order to temporarily seal the perforation. 
Great difficulty is expected to implant the coated stent, 
due to tortuosity, marked calcification, or previous stent 
in the proximal segment. Thus, surgeons will save time 
and find it easier to implant a stent coated with PTFE, 
providing a more safe procedure, avoiding a surgical 
intervention, and decreasing the mortality associated 
with this complication of PCI.
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